Nasdaq
$0.9089▲ 1.27%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $74.8MShares out 82.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 10.6After-hours26.10.07 05:068-KKey event#●●●
INOVIO PHARMACEUTICALS, INC.
Inovio Pharmaceuticals, Inc. amended its bylaws on October 6, 2026, to establish exclusive forum provisions. Under these new rules, internal corporate claims must be brought in the Delaware Court of Chancery, while claims arising under the Securities Act of 1933 are restricted to U.S. federal district courts.…more
$0.9089+1.27%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.12After-hours26.08.13 05:078-KKey event
INOVIO PHARMACEUTICALS, INC.
Inovio reported zero revenue and a net loss of $6.0 million ($0.07 per share) for the second quarter of 2026. The FDA review for its lead candidate, INO-3107, is ongoing with a PDUFA target date of October 30, 2026. The company stated that its current cash, including $18.3 million in net proceeds from a July 2026 offering, is sufficient to fund operations into the late first quarter of 2027.…more
$0.9089+1.27%vs prev closeView filingShare - 8.12After-hours26.08.13 05:0010-QEarnings
INOVIO PHARMACEUTICALS, INC.
Inovio Pharmaceuticals has filed its Form 10-Q for the second quarter of 2026, detailing the company's financial condition and operational results. The report includes comprehensive disclosures regarding capital raising activities, specifically the equity offerings conducted in April and July 2026. Management has officially certified that the financial statements fairly present the company's financial position for the reported period.…more
$0.9089+1.27%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoAfter-hours26.10.21 05:09#●●●
Inovio Wins $80M Judgment Against VGXI and GeneOne
Inovio has secured an $80.4 million judgment against VGXI and GeneOne in a legal dispute. However, the company noted that the defendants' current financial condition may hinder the actual collection of these funds.…more
$0.9089+1.27%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga